Evaluation and management of recurrent spontaneous abortion

Current Opinion in Obstetrics and Gynecology

Volumn 8, Issue 3, 1996, Pages 188-192

  Daya, Salim ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; FATTY ACID; IMMUNOGLOBULIN; LIPID PEROXIDE; PLACENTA PROTEIN 14;

CELLULAR IMMUNITY; CLINICAL TRIAL; FEMALE; HELPER CELL; HUMAN; IMMUNIZATION; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE; LIPID PEROXIDATION; LUTEAL PHASE; META ANALYSIS; OLIGOMENORRHEA; OXIDATIVE STRESS; PRIORITY JOURNAL; RECURRENT ABORTION; REVIEW; SPONTANEOUS ABORTION; TRANSVAGINAL ECHOGRAPHY;

EID: 0029975384     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199606000-00007     Document Type: Review

References (23)

1. US Department of Health and Human Services: Reproductive Impairment Among Married Couples. US Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics; 1982; series 23, 11:5-31.
2. Hill JA, Polgar K, Harlow BL, Anderson DJ: Evidence of embryo- and trophoblast-toxic cellular immune response(s) in women with recurrent spontaneous abortion. Am J Obstet Gynecol 1992, 166:1044-1052.
3. Ecker JL, Laufer M, Hill JA: Measurement of embryo toxic factors is predictive of pregnancy outcome in women with a history of recurrent abortion. Obstet Gynecol 1993, 81:84-87.
4. Yamada H, Polgar K, Hill JA: Cell-mediated immunity to trophoblast antigens in women with recurrent spontaneous abortion. Am J Obstet Gynecol 1994, 170:1339-1344.
5. Hill JA, Polgar K, Anderson DJ: T-helper 1-type immunity to • trophoblast in women with recurrent spontaneous abortion. JAMA 1995, 273:1933-1936. This study showed a T helper immune response to trophoblast antigens.
6. Sane AS, Chokshi SA, Mishra W, Barad DP, Shah VC, Nagpal S: Serum lipoperoxides in induced and spontaneous abortions. Gynecol Obstet Invest 1991, 31:172-175.
7. Nicotia M, Multinelli C, Sbracia M, Rolf G, Passi S: Blood levels of lipids, lipoperoxides, vitamin E and glutathione peroxidase in women with habitual abortion. Gynecol Obstet Invest 1994, 38:223-226.
8. Stray-Pedersen B, Stray-Pederson S: Recurrent abortion: the role of psychotherapy. In Early Pregnancy Loss: Mechanisms and Treatment. Edited by Beard RW, Sharp F. Ashton-under-Lyne, England: Peacock Press; 1988:433-440.
9. Julkunen M, Rutanen E-M, Kostermies A, Ranta T, Bohn H, Seppala M: Distribution of placental protein 14 in tissues and body fluids during pregnancy. Br J Obstet Gynaecol 1985, 2:1145-1151.
10. Bolton E, Pockley AG, Clough KJ, Mowles EA, Stoker RJ, Westwood OMR, Chapman MG: Identification of placental protein 14 as an immunosuppressive factor in human reproduction. Lancet 1987, I:593-595.
11. Tulppala M, Julkunen M, Tiitinen A, Stenman U-H, Seppala M: Habitual abortion is accompanied by low serum levels of placental protein 14 in the luteal phase of the fertile cycle. Fertil Steril 1995, 63:792-795.
12. Tulppala M, Julkunen M, Tiitinen A, Stenman U-H, Seppala M: Habitual abortion is accompanied by low serum levels of placental protein 14 in the luteal phase of the fertile cycle. Fertil Steril 1995, 63:792-795.
13. Okamoto N, Uchida A, Takakura K, Kariya Y, Kamazaki H, Riittinen L, Koistinen R, Seppala M, Tori T: Suppression by human placental protein 14 of natural killer cell activity and T cell proliferative response. Am J Reprod Immunol 1991, 26:137-142.
14. Wahlstrom T, Koskimies AI, Tenhunen A, Rutanen E-M, Yki-Jarvinen M, Sjoberg J, Seppala M: Pregnancy proteins in the endometrium after follicle aspiration for in vitro fertilization. Ann NY Acad Sci 1985, 442:402-407.
15. Dickey RP, Gasses RF, Olar TT, Taylor SN, Curole DN, Rye PH, Matulich EM: Risk of recurrent abortion after appearance of a chorionic sac or heart rate on a]vaginal ultrasound. Lancet 1994, 344:442-443.
16. Daya S, Gunby J, The Recurrent Miscarriage Immunotherapy Trialists • Group: The effectiveness of allogeneic leukocyte immunization in unexplained primary recurrent spontaneous abortion. Am J Reprod Immunol 1994, 32:294-302. This collaborative meta-analysis of individual patient data showed that the probability of live birth was reduced by 23% for each additional abortion beyond three that the patient had experienced.
17. Quenby S, Farquharson RG: Human chorionic gonadotropin • supplementation in recurring pregnancy loss: a controlled trial. Fertil Steril 1994, 62:708-710. In this study hCG treatment resulted in a success rate of 85% compared with 40% using placebo.
18. Mowbray JF, Liddel H, Underwood JL, Gibbings C, Reginald PW, Beard RW: Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells. Lancet 1985, 1:941-943.
19. Clark DA, Daya S: Trials and tribulations in the treatment of recurrent spontaneous abortion. Am J Reprod Immunol 199125:18-24.
20. The Recurrent Mischarriage Immunotherapy Trialists Group: Worldwide • collaborative observational study and meta-analysis on ellogeneic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1994, 32:55-72. This worldwide collaborative observational study organized under the auspices of the Ethics Committee of the American Society of Reproductive Immunology reported a significant improvement in the live birth rate with immunotherapy.
21. Mueller-Eckhardt G, Heine O, Neppert J, Kunzel W, Mueller-Eckhardt C: Prevention of recurrent spontaneous abortion by intravenous immunoglobulin. Vox Sang 1989, 51:122-126.
22. The German RSA/IVIG Group: Intravenous immunoglobulin in the • prevention of recurrent miscarriage. Br J Obstet Gynaecol 1994, 101:1072-1077. A German multicentered, double-blind, randomized, controlled trial conducted with women with unexplained primary recurrent abortion comparing IVIG with 5% human albumin given as placebo. No significant difference in success rates between the IVIG and placebo groups was observed.
23. Coulam CB: Alternative treatment to lymphocyte immunization for treatment of recurrent spontaneous abortion. Immunogherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience. Am J Reprod Immunol 1994, 32:286-289.